Chembio Diagnostic Systems is a company that develops a serological test for active tuberculosis. It offers a test that detects specific antibodies using Dual Path Platform (DPPTM) technology and selected antigens from a panel of recombinant antigens. The company provides its product for point-of-care or field applications.